Research graph
References from Synergistic effect of antibiotic combinations on Staphylococcus aureus biofilms and their persister cell populations. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2014 · External reference
Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review
10.3389/fmicb.2019.00539 · 2019 · External reference
The antibiotic resistance crisis: causes and threats
2015 · External reference
Persister cells and the paradox of chronic infections
2010 · External reference
Unresolved reference
2019 · External reference
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli
10.1128/jb.186.24.8172-8180.2004 · 2004 · External reference
Treatment strategies targeting persister cell formation in bacterial pathogens
10.1080/1040841x.2020.1822278 · 2020 · External reference
Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies
10.1099/jmm.0.030932-0 · 2011 · External reference
Combatting bacterial persister cells; Combatting bacterial persister cells
10.1002/bit.25721 · 2016 · External reference
Optimizing antimicrobial therapy of sepsis and septic shock
2015 · External reference
Differential activity of the combination of vancomycin and amikacin on planktonic vs. Biofilm-growing Staphylococcus aureus bacteria in a hollow fiber infection model
10.3389/fmicb.2018.00572 · 2018 · External reference
Antibiotic tolerance in biofilm and stationary-phase planktonic cells of Staphylococcus aureus
2020 · External reference
When does 2 plus 2 equal 5? A review of antimicrobial synergy testing downloaded from. 4124
10.1128/jcm.01121-14 · 2014 · External reference
Time-dependent enhanced resistance against antibiotics & metal salts by planktonic & biofilm form of Acinetobacter haemolyticus MMC 8 clinical isolate
2014 · External reference
Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents
10.2147/ijn.s24793 · 2012 · External reference
Staphylococcus aureus persisters tolerant to bactericidal antibiotics
2012 · External reference
In vitro activity of vancomycin combined with rifampin, amikacin, ciprofloxacin or imipenem against methicillin-resistant and methicillin-susceptible Staphylococcus aureus
10.1111/j.1469-0691.1998.tb00349.x · 1998 · External reference
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth
10.1128/aac.01480-07 · 2008 · External reference
Applications of metal nanoparticles to combat biofilm-forming ESKAPE pathogens
2019 · External reference
Strategies for combating bacterial biofilm infections
10.1038/ijos.2014.65 · 2015 · External reference
Antibiotic treatment of biofilm infections
10.1111/apm.12673 · 2017 · External reference
Evaluation of ceftaroline alone and in combination against biofilm-producing methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin and vancomycin in an in vitro pharmacokinetic/pharmacodynamic model
10.1128/aac.00386-15 · 2015 · External reference
Antimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devices
10.1016/j.jiac.2015.06.001 · 2015 · External reference
Meropenem and vaborbactam: stepping up the battle against carbapenem-resistant enterobacteriaceae
10.1002/phar.2092 · 2018 · External reference
Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo
10.1371/journal.pone.0113133 · 2014 · External reference
Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection
10.1016/j.ejvs.2010.08.009 · 2010 · External reference
Unresolved reference
2012 · External reference
Serum levels of ciprofloxacin after single oral doses in patients with septicemia
10.1007/bf01975162 · 1989 · External reference
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
10.1128/aac.00247-06 · 2006 · External reference
Unresolved reference
External reference
Evaluation of serum concentrations achieved with an empiric once-daily tobramycin dosage regimen in children and adults with cystic fibrosis
2012 · External reference
Combatting Bacterial Persister cell infections by auranofin?
10.1016/j.biopha.2017.07.022 · 2017 · External reference
Quorum sensing-regulated phenol-soluble modulins limit persister cell populations in Staphylococcus aureus
10.3389/fmicb.2018.00255 · 2018 · External reference
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
10.1126/scitranslmed.aan4044 · 2018 · External reference
Fighting bacterial persistence: current and emerging anti-persister strategies and therapeutics
10.1016/j.drup.2018.03.002 · 2018 · External reference
A new class of synthetic retinoid antibiotics effective against bacterial persisters
10.1038/nature26157 · 2018 · External reference
Strategies against methicillin-resistant Staphylococcus aureus persisters
10.4155/fmc-2017-0199 · 2018 · External reference
Engineering persister-specific antibiotics with synergistic antimicrobial functions
10.1021/nn502201a · 2014 · External reference
Activated ClpP kills persisters and eradicates a chronic biofilm infection
10.1038/nature12790 · 2013 · External reference
A clinical drug library screen identifies tosufloxacin as being highly active against Staphylococcus aureus persisters
10.3390/antibiotics4030329 · 2015 · External reference
Antibacterial and photocatalytic activities of 5-nitroindole capped bimetal nanoparticles against multidrug resistant bacteria
10.1016/j.colsurfb.2020.110825 · 2020 · External reference
Antibiofilm and antipersister activity of acetic acid against extensively drug resistant Pseudomonas aeruginosa PAW1
10.1371/journal.pone.0246020 · 2021 · External reference
